title: How research on stakeholder perspectives can inform policy on cognitive enhancement.
authors.affiliation: Institut de recherches cliniques de Montreal, Canada.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Forlini
authors.forename: Eric
authors.initials: E
authors.lastname: Racine
authors.forename: Jochen
authors.initials: J
authors.lastname: Vollmann
authors.forename: Jan
authors.initials: J
authors.lastname: Schildmann
mesh_terms: D000661:Amphetamine; D000697:Central Nervous System Stimulants; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D008774:Methylphenidate; D018697:Nootropic Agents; D011640:Public Policy / Q000331:legislation & jurisprudence*; D019966:Substance-Related Disorders / Q000209:etiology*
chemical_list: D000697:Central Nervous System Stimulants; D018697:Nootropic Agents; D008774:Methylphenidate; D000661:Amphetamine